These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro), which is a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 agonist
Tissues most affected BPC-157s mechanism of action impacts various tissues, including: Tendons and ligaments : Improves collagen production and strengthens connective tissues
They may return if the injection is repeatedly given in the same spot, which is why healthcare providers recommend rotating injection sites for example, alternating between the abdomen, thigh, or upper arm each week
Those considering this future treatment should consult with Retatrutide doctors for the most current and comprehensive information